Lower frequency of SARS-CoV-2-associated severe respiratory infections among adults vaccinated against the 2021/22 season influenza - 06/06/23
Doi : 10.1016/j.resmer.2022.100979
Alexander Domnich a, Giovanna Milano b, Elena Capitani b, Andrea Camarri c, Giovanni Bova c, Pier Leopoldo Capecchi d, Emanuele Montomoli b, e, f, Ilaria Manini b, f, ⁎ 
a Hygiene Unit, San Martino Policlinico Hospital – IRCCS for Oncology and Neurosciences, Genoa, Italy
b Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
c Emergency and Transplants Department, University Hospital of Siena, Siena, Italy
d Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy
e VisMederi S.r.l., Siena, Italy
f Interuniversity Research Centre on Influenza and Other Transmissible Infections (CIRI-IT), Genoa, Italy
⁎Corresponding author at. Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.Department of Molecular and Developmental MedicineUniversity of SienaVia Aldo Moro 2Siena53100Italy
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : SARS-CoV-2, COVID-19, Vaccination, Influenza vaccines, Severe acute respiratory infection
© 2022
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83
Article 100979- juin 2023 Retour au numéro
Article précédent
- Changes in body weight reflect disease progression in pleuroparenchymal fibroelastosis
- Yoshiaki Kinoshita, Takuhide Utsunomiya, Yohei Koide, Kenji Wada, Yusuke Ueda, Yuji Yoshida, Hisako Kushima, Hiroshi Ishii
- The pandemic effect: The outlook of lung transplantation
- Rene Aleman, Federico Napoli, Joel S. Frieder, NE Jorge Balzan, Cedric Sheffield, Jose Navia, Nicolas A. Brozzi
Bienvenue sur EM-consulte, la référence des professionnels de santé.